Clinical Trial Update: Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone [Phase 4]

View source ↗

Summary

Phase 4 trial comparing two regimens of biphasic insulin aspart 30 in adults with Type 2 diabetes not at HbA1c target on oral antidiabetic drugs; results comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Novolog Mix 30 (biphasic insulin aspart 30 (BIAsp 30))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2013-11-25